Results 11 to 20 of about 100,926 (300)

Antipsychotic exposure is an independent risk factor for breast cancer: A systematic review of epidemiological evidence

open access: yesFrontiers in Oncology, 2022
BackgroundThe effect of antipsychotics on breast cancer remains controversial.Materials and methodsEmbase, Scopus, PubMed, Web of Science, Cochrane Library, and Hebei Medical University Library were used for the literature search.
Zheng Gao   +5 more
doaj   +1 more source

Antipsychotics use in dementia: How safe are they?

open access: yesEuropean Psychiatry, 2021
Introduction Antipsychotics are frequently used for managing psychiatric and behavioral symptoms of dementia. However, it’s an off-label resource which remains controversial due to significant safety concerns in the elderly population, namely ...
C. Lopes
doaj   +1 more source

Antipsychotics use in the community of Thessaloniki, Greece [PDF]

open access: yesVojnosanitetski Pregled, 2018
Background/Aim. Under the current financial crisis in Greece, an effort has been made by the Greek health authorities to encourage generic prescribing, in order to lower medicinal cost.
Papaioannidou Paraskevi   +1 more
doaj   +1 more source

Antipsychotics and Amotivation [PDF]

open access: yesNeuropsychopharmacology, 2015
Antipsychotic drugs are thought to produce secondary negative symptoms, which can also exacerbate primary negative symptoms. In the present study, we examined whether motivational deficits in particular were related to antipsychotic treatment in patients with schizophrenia in a dose-dependent manner.
Gagan, Fervaha   +6 more
openaire   +2 more sources

Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects

open access: yesBMC Psychiatry, 2009
Background Although much progress has been made on antipsychotic drug development, precise mechanisms behind the action of typical and atypical antipsychotics are poorly understood.
Song Jonathan   +7 more
doaj   +1 more source

Hyperprolactinemia as a side effect of using antipsychotics In Schizophrenic Patients

open access: yesJurnal Psikiatri Surabaya, 2023
Introductions: Antipsychotics are still the mainstay of schizophrenia management. Antipsychotics are antagonistic to postsynaptic dopamine receptors in the brain.
Syaiful Anwar, Khairina
doaj   +1 more source

Risk of Mortality (including Sudden Cardiac Death) and Major Cardiovascular Events in Users of Olanzapine and Other Antipsychotics: A Study with the General Practice Research Database. [PDF]

open access: yes, 2013
Objective. Assess risk of cardiac events and mortality among users of olanzapine and other antipsychotics relative to nonusers. Methods. The General Practice Research Database was used to identify cohorts of antipsychotic users and nonusers with ...
Van Staa, Tjeerd; id_orcid   +8 more
core   +1 more source

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis [PDF]

open access: yes, 2000
Objective To develop an evidence base for recommendations on the use of atypical antipsychotics for patients with schizophrenia.Design Systematic overview and meta-regression analyses of randomised controlled trials, as a basis for formal development of ...
Freemantle, Nick   +9 more
core   +1 more source

Adherence to typical antipsychotics

open access: yes, 2022
 There has been a recent transition from typical to atypical antipsychotics in the management of schizophrenia. This has been attributed to the acute side effects experienced by patients on typical antipsychotics that lead to non-adherence.
Mark Mohan Kaggwa (10733064)
core   +2 more sources

Comparison of relapse rates of depot and oral antipsychotics in patients with schizophrenia [PDF]

open access: yes, 2017
Introduction: Antipsychotics are the mainstay of treatment in schizophrenia. First-generation and second-generation antipsychotics are available as oral and depot formulations.
Morrissey, Hana   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy